Comparing two surgical methods for treating prostate enlargement while preserving ejaculation
Official title: Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction
Run by University Hospital, Bordeaux · NCT05574244 · Data updated 2026-11-12
This study is testing two different surgical methods for treating prostate enlargement in men to see which one helps improve urinary symptoms while also preserving the ability to ejaculate.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years and up |
| Sex | Men only |
| Enrollment | 336 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 17 sites (Aix-en-Provence and 16 other locations) |
| Status | Recruiting |
| Started | September 29, 2022 |
| Main results expected | March 31, 2029 |
| Study ends | March 31, 2029 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT05574244 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are men over 40 with benign prostatic hyperplasia requiring surgical intervention and meeting specific clinical criteria.
✕Probably not a fit
Patients who have no pre-operative ejaculation or sexual activity, or those with certain medical histories such as prostate cancer, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the effectiveness of partial transurethral resection of the prostate with conventional transurethral resection for men suffering from benign prostatic hyperplasia. It focuses on improving lower urinary tract symptoms and preserving ejaculatory function, which is often compromised by traditional surgical methods. The trial employs a multicenter randomized design with single-blinded patients, assessing outcomes at six months post-surgery. Key measures include urinary flow, sexual life quality, and complication rates.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for men by preserving sexual function while effectively treating urinary symptoms.
How similar studies have gone: Previous studies have shown promising results with modified surgical techniques aimed at preserving ejaculation, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Man over 40 years old * Indication of surgical management for BPH * Prostate volume ≥30 cc and ≤150 cc as evaluated by ultrasonography ( or an MRI if available) * IPSS score ≥12 * Qmax ≤15 ml/s * Affiliated to French national social security system * wish and be able to comply with planned visits * Able to express his consent * Signed informed consent form Exclusion Criteria: * Unwillingness to accept the treatment * No pre-operative ejaculation or sexuality * Neurological pathology responsible for micturition disorders * History of prostatic surgery * Stenosis of the urethra symptomatic * History of prostate cancer * History of radiotherapy or pelvic surgery * Patient refusing the principle of partial surgery * Life expectancy \<3 years * Inability to understand the informed consent document, to give consent voluntarily or to complete the study tasks. * Participation in another clinical study involving an investigational product within 1 month before study entry.
Where it's running
-
CH Pays d'Aix
Aix-en-Provence, France Recruiting -
CHU Angers
Angers, France Recruiting -
Centre Hospitalier Universitaire de Bordeaux
Bordeaux, France Recruiting -
CHU de Limoges
Limoges, France Recruiting -
Hôpital Nord Marseille
Marseille, France Recruiting -
Polyclinique Saint George
Nice, France Recruiting
Show 11 more locations
-
Hôpital cochin
Paris, France Recruiting -
Hôpital Prive Francheville
Périgueux, France Recruiting -
Hôpital Lyon Sud HCl Bât.3C Centre Hospitalier Lyon Sud
Pierre-Bénite, France Recruiting -
Hôpital Privé des Côtes D'Armor
Plérin, France Recruiting -
CHU de Reims- Hôpital Robert Debré
Rennes, France Recruiting -
CHU de Rennes
Rennes, France Recruiting -
Hopital Privé de Versailles, Clinique des Franciscaines
Versailles, France Recruiting -
CHU Mondor
Créteil, France Withdrawn -
Hôpital Claude Huriez
Lille, France Withdrawn -
Clinique Pasteur
Toulouse, France Withdrawn -
CHRU Hôpitaux de tours
Tours, France Withdrawn
Study contacts
- Study coordinator: Grégoire ROBERT
- Email: gregoire.robert@chu-bordeaux.fr
- Phone: 05.57.82.06.87
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sonablate HIFU Registry for Prostate Cancer and BPH
This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.
-
Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate
This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.
-
MRI-DTI look at the urethral sphincter ring and prostate base shape
This imaging study tests how the male urethral internal sphincter ring appears on MRI-DTI and how it relates to prostate base morphology in men undergoing clinically indicated MRI.
-
Tamsulosin With or Without Tadalafil for a Trial Without Catheter After Acute Urinary Retention
This study tests whether adding tadalafil to tamsulosin helps men with a first episode of acute urinary retention due to enlarged prostate pass urine without needing a catheter.
-
Tamsulosin dose change or switch to silodosin before catheter removal in men with BPH-related acute urinary retention
This trial tests whether continuing tamsulosin, increasing its dose, or switching to silodosin helps men with BPH-related acute urinary retention go without a catheter after seven days.
-
Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia
This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.